SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The revenue for the December 2022 quarter is pegged at Rs. 0.00 millions against Rs. 0.00 millions recorded during the year-ago period.The Total Profit for the quarter ended December 2022 of Rs. 0.19 millions grew from Rs.-0.34 millions Operating profit Margin for the quarter ended December 2022 improved to 0.20% as compared to -0.32% of corresponding quarter ended December 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.68 0.00
Other Income 0.50 0.00 0.00 1.50 0.00 0.00 19.83 1.81 995.58
PBIDT 0.20 -0.32 -162.50 0.40 -0.96 -141.67 18.56 -1.53 -1313.07
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 0.20 -0.32 -162.50 0.40 -0.96 -141.67 18.56 -1.53 -1313.07
Depreciation 0.02 0.02 0.00 0.06 0.06 0.00 0.09 0.10 -10.00
PBT 0.18 -0.34 -152.94 0.34 -1.02 -133.33 18.47 -1.63 -1233.13
TAX -0.01 0.00 0.00 -0.01 0.00 0.00 0.00 0.01 0.00
Deferred Tax -0.01 0.00 0.00 -0.01 0.00 0.00 0.00 0.01 0.00
PAT 0.19 -0.34 -155.88 0.35 -1.02 -134.31 18.47 -1.64 -1226.22
Equity 52.39 52.39 0.00 52.39 52.39 0.00 52.39 52.39 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -91.07 0.00

Venmax Drugs&Pharma Share Price

24.79 -1.26 (-4.84%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×